It is with great pride we announce that CEO and Professor Ali Salanti, Department of Cellular and Molecular Medicine, on May 24th 2017 recieved the prestigeous ERC Proof of Concept grant of Euro 150,000 over 18 months. The grant is an important contribution to our efforts to develop our novel methods for cancer diagnosis. For more information, follow this link.